Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Amt, My01, Renovacare, Viome.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advanced Regenerative Associates, Aditx Therapeutics, Aegis Spine, Akumin, American Cryostem, BD, Cirrusmd, Daxor, Eli Lilly, Feinstein Institutes, Flexcare Digital Health, GE Healthcare, Glooko, Imflux, L&K Biomed, Life Spine, Molecular Loop, Moleculight, Nemaura Medical, Net Health Systems, Proctor & Gamble, Profound Medical, Quidel, Recuro Health, Rhinostics, RNA Disease Diagnostics, Roche Holding AG, Technimark, Tissue Analytics, Udotest, Walgreens, Watchmaker Genomics, Zionexa.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Everest, Lyndra, Merck & Co., RDIF.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abcellera, Achilles, Aeterna, Angios, Applied DNA, Aptorum, Asieris, Beigene, BMS, CSL, Darwinhealth, Enesi, Evvivax, Fusion, Generex, Inspira Pharma, Insud, ITM, Jasper, Lexaria, Merck & Co., Mimedx, Moderna, Molecular Partners, Neuropathix, Nova Mentis, Novavax, Ocugen, Sanofi, Seven Bridges, Springworks, Trevena, Uniqure, Vectura, Yiling, Youfeng, ZS.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acelrx, AGTC, Altavant, Arcutis, Cytokinetics, Follicum, Hepion, Horizon, Humanigen, Isofol, Moderna, Moonlake, Nervgen, Novavax, Peptomyc, Revelation, Stealth, Surface Ophthalmics, Tetra, Zynerba.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Autogen, Axim Biotechnologies, Cell Projects, Centogene, CN Bio, Eagle Genomics, Empowered Diagnostics, Exagen, Femselect, Fluxergy, Gene Group Holdings, Genostics, Heartflow, Isohelix, Konica Minolta, Lina Medical USA, Medaxiom, Nvoq, Oncimmune, Perahealth, Rxbio, Sientra, Spectrum Solutions, Stagezero, United Health Products, US Medical Innovations, Vtnc.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 4DMT, Alchemab, Astrazeneca, Alligator, Athenex, Celularity, Cytodyn, Dancann, Enesi, Errant Gene, Fraunhofer, GW, GX, Hoth, Ibio, Jazz, Kuur, Laboratorios Grin, Leadgen, Lupin, Mindmed, Mydecine, Nicox, Olix, Palantir, PCI, San Rocco, Takanawa, Takara, Tetra, Tiziana.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adagio, Ascletis, Catalyst, Cerecor, Genascence, Genprex, Neoleukin, Oncopeptides, Tilt, Vivace.